articleThe LancetOct 1, 2023GREEN OA

Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials

Ophthalmic Consultants of Boston · Duke Medical Center · +20 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

423
total citations
FWCI
111.45
Percentile
100%
References
28
Citations per year

Authors

261

Topics & keywords

Keywords
  • Medicine
  • Macular degeneration
  • Population
  • Geographic atrophy
  • Clinical endpoint
  • Clinical trial
  • Atrophy
  • Ophthalmology
UN Sustainable Development Goals
  • Quality Education
No related works found for this paper.

Funding